Cytotherapy (journal): Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 33: | Line 33: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:Cytotherapy_(journal).jpg|Cytotherapy (journal) | |||
</gallery> | |||
Latest revision as of 21:34, 20 February 2025
Cytotherapy is a peer-reviewed medical journal that focuses on the field of cell therapy. The journal is published by Elsevier and is the official journal of the International Society for Cellular Therapy.
Overview[edit]
Cytotherapy was first published in 1999 and covers all aspects of cell therapy and regenerative medicine. The journal publishes original research articles, review articles, and clinical studies related to the biology, sources, production, and uses of cells for therapy.
The journal's scope includes topics such as stem cell therapy, immunotherapy, gene therapy, and tissue engineering. It also covers the regulatory and ethical issues related to cell therapy.
Abstracting and indexing[edit]
Cytotherapy is abstracted and indexed in PubMed, Scopus, Embase, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 3.553.
Editorial board[edit]
The editor-in-chief of Cytotherapy is John Barrett, who is affiliated with the National Institutes of Health. The journal's editorial board includes experts in the field of cell therapy from around the world.
See also[edit]
-
Cytotherapy (journal)
